Roche Molecular Diagnostics Global

CT/NG Testing
Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) DNA using microwell plates (AMPLICOR) or fully automated analyzers.

HPV Detection and Genotyping
The key to assessing cervical cancer risk is accurate information about HPV. Tests for detection of high- and low-risk HPV genotypes.

See our Legal Statement - Privacy Policy

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

Roche Molecular Diagnostics operates in the U.S. as the legal entity Roche Molecular Systems, Inc.